Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes
Open Access
- 15 September 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (6) , 745-747
- https://doi.org/10.1172/jci11088
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Role of perforin in controlling B-cell hyperactivity and humoral autoimmunityJournal of Clinical Investigation, 2000
- Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand–deficient miceJournal of Clinical Investigation, 2000
- Perforin Gene Defects in Familial Hemophagocytic LymphohistiocytosisScience, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.Journal of Clinical Investigation, 1998
- How do cytotoxic lymphocytes kill their targets?Current Opinion in Immunology, 1998
- Enhanced Antibody and Cytokine Responses to Influenza Viral Antigens in Perforin-Deficient MiceCellular Immunology, 1998
- Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.Journal of Clinical Investigation, 1997
- Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin functionProceedings of the National Academy of Sciences, 1997
- Is chronic graft versus host disease an autoimmune disease?Current Opinion in Immunology, 1993